Inactive Instrument

Press Releases Exicure Inc Other OTC

Equities

US30205M1018

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

Exicure, Inc. Received Nasdaq Delinquency Notice on Late Filing of its Form 10-K	04-22	BU
Exicure, Inc. and Bluejay Therapeutics Inc. Enter into a Patent License Agreement to Develop Cavrotolimod for the Treatment of Hepatitis	02-05	BU
Exicure : Non-Reliance on Previously Issued Financial Report - Form 8-K	12-01	PU
Exicure, Inc. Received Nasdaq Delinquency Notice on Late Filing of its Form 10-Q	11-28	BU
Exicure, Inc. Announces Appointment of New CEO and CFO and Changes to Board of Directors	23/08/23	BU
Exicure : Announces Appointment of New CEO and CFO and Changes to Board of Directors - Form 8-K	23/08/23	PU
Exicure, Inc. Reports Second Quarter 2023 Financial Results and Provides Corporate Update	14/08/23	AQ
Exicure, Inc. Reports Second Quarter 2023 Financial Results and Provides Corporate Update	11/08/23	BU
Exicure Reports First Quarter 2023 Financial Results and Provides Corporate Update	17/07/23	AQ
Exicure, Inc. Reports First Quarter 2023 Financial Results and Provides Corporate Update	14/07/23	BU
EXICURE, INC. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	14/06/23	AQ
Exicure, Inc. Announces Support of CEO in its Ongoing Exploration of Strategic Alternatives	29/05/23	AQ
Exicure, Inc. Announces Support of CEO in its Ongoing Exploration of Strategic Alternatives	26/05/23	BU
Exicure, Inc. Received Nasdaq Delinquency Notice on Late Filing of its Form 10-Q	19/05/23	BU
EXICURE, INC. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)	18/05/23	AQ
EXICURE, INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits (form 8-K)	11/05/23	AQ
EXICURE, INC. : Entry into a Material Definitive Agreement, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	09/05/23	AQ
INCEPTOR BIO APPOINTS MATTHIAS SCHROFF, PHD, AS CHIEF EXECUTIVE OFFICER	09/05/23	AQ
EXICURE, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	04/05/23	AQ
Exicure, Inc. Announces Investment in Korean SNS Platform Cyworld	04/05/23	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Exicure Inc Other OTC

Equities

US30205M1018

Press Releases

Filters